The company will not receive any of the proceeds from the sale of ordinary shares by the selling shareholder. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on EVGN: Evogene Announces Major Management Restructuring Evogene Ltd. Reports Mid-Year Financial Dip Evogene Issues Series A Share Purchase Warrants Evogene price target lowered to $12 from $30 at Lake Street Evogene announces pricing of $5.5M registered direct offering Disclaimer & DisclosureReport an Issue